135 results on '"Small, T N"'
Search Results
2. Live (vaccines) from New York
3. Alternative donor SCT for the treatment of MHC Class II deficiency
4. Legionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection
5. Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT
6. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease
7. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation
8. T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia
9. Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial)
10. Vaccination of SCT recipients
11. Pre- and post-engraftment bloodstream infection rates and associated mortality in allogeneic hematopoietic stem cell transplant recipients
12. Safe and Cost Effective Use of Alteplase for the Clearance of Occluded Central Venous Access Devices
13. Erratum: Legionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection
14. Immunogenetic Analysis of HLA Class II Cellular Data
15. Binding Patterns of the Monoclonal Antibodies in the 10th Workshop 2-D Gel Analysis of Class II Antigens
16. Alternative donor SCT for the treatment of MHC Class II deficiency
17. Live (vaccines) from New York
18. Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency
19. T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia
20. Comparison of immune recovery in recipients of unmanipulated vs T-cell-depleted grafts from unrelated donors in a multicenter randomized phase II–III trial (T-cell depletion trial)
21. Vancomycin-resistant enterococcus (VRE) in pediatric oncology patients: An analysis of potential consequences of colonization and infection
22. Treatment outcome after induction chemotherapy before allogeneic hematopoietic SCT in patients with advanced MDS
23. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma.
24. Absence of interleukin 2 production in a severe combined immunodeficiency disease syndrome with T cells.
25. Differential expression and regulation of the human CD8α and CD8β chains
26. Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation.
27. Risk of extramedullary relapse following allogeneic bone marrow transplantation for acute myelogenous leukemia with leukemia cutis.
28. The Role of Residual Host Immunity in Graft Failures following T-cell-depleted Marrow Transplants for Leukemiaa.
29. Immunologic reconstitution following stem cell transplantation.
30. The role of residual host immunity in graft failures following T-cell-depleted marrow transplants for leukemia
31. Graft failures after T cell depleted marrow tranplants for leukemia: clinical and in vitro characteristics
32. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: II. In vitro analyses of host effector mechanisms
33. Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations
34. A phase II trial of peri-transplant palifermin with busulfan, melphalan and fludarabine followed by T-cell depleted hematopoietic stem cell transplants in patients with advanced myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) evolved from MDS
35. T-cell depleted (TCD) hematopoietic stem cell (HSC) boosts from the original donor without conditioning for poor graft function (PGF) following allogeneic hematopoietic stem cell transplants (HSCT)
36. High-resolution DNA typing for HLA-A, -B, and -DRB1 has direct impact on the survival in the recipients of unrelated donor (URD) hematopoietic stem cell transplant (HSCT)
37. A phase I-II dose escalation trial of clofarabine plus melphalan and thiotepa followed by unmodified allogeneic stem cell transplant (SCT) for the treatment of high risk or advanced acute leukemia
38. Improved survival in patients with refractory cytopenias (low risk myelodysplastic syndrome - MDS) treated with allogeneic T-cell depleted hematopoietic stem cell transplants (allo TCD-HSCTs)
39. Improved outcome with T-cell depleted (SBA(-)E(-)) marrow transplants from related and unrelated donors for children with acute leukemia transplanted in first or second remission
40. M241 (CD1) expression on B lymphocytes.
41. Posterior Leukoencephalopathy Syndrome May Not Be Reversible
42. Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.
43. Respiratory syncytial virus infection following hematopoietic stem cell transplantation.
44. Lung transplantation after allogeneic marrow transplantation in pediatric patients: the Memorial Sloan-Kettering experience.
45. Stem cell transplantation for the treatment of Fanconi anaemia using a fludarabine-based cytoreductive regimen and T-cell-depleted related HLA-mismatched peripheral blood stem cell grafts.
46. Association of reticular dysgenesis (thymic alymphoplasia and congenital aleukocytosis) with bilateral sensorineural deafness.
47. Comparison of immune reconstitution after unrelated and related T-cell-depleted bone marrow transplantation: effect of patient age and donor leukocyte infusions.
48. Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study.
49. Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient.
50. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.